These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10256892)

  • 21. FTC: our model product selection law relies on the pharmacist's expertise.
    Holmes PD
    Pharm Times; 1979 Feb; 45(2):36-9. PubMed ID: 10240271
    [No Abstract]   [Full Text] [Related]  

  • 22. Generic substitution laws--physicians' liability.
    Trout ME
    J Leg Med (N Y); 1977 Jul; 5(7):14-6. PubMed ID: 301915
    [No Abstract]   [Full Text] [Related]  

  • 23. Liability of pharmacists for substitution of a generic drug for its brand-name counterpart.
    Hirsh HL
    Med Law; 1987; 6(4):293-302. PubMed ID: 3613889
    [No Abstract]   [Full Text] [Related]  

  • 24. Anti-substitution law repeal--pro and con: the case against repeal.
    Perloff MM
    Am J Pharm Sci Support Public Health; 1971; 143(1):15-23. PubMed ID: 5162747
    [No Abstract]   [Full Text] [Related]  

  • 25. Forces and direction of drug product selection legislation.
    Stewart JE
    Med Mark Media; 1979 Jun; 14(6):34-6, 38-9. PubMed ID: 10242281
    [No Abstract]   [Full Text] [Related]  

  • 26. Test based on natural processes cannot be patented, rules US court.
    Dyer C
    BMJ; 2012 Mar; 344():e2290. PubMed ID: 22446741
    [No Abstract]   [Full Text] [Related]  

  • 27. Educating patients about their medications: the potential and limitations of written drug information.
    Shrank WH; Avorn J
    Health Aff (Millwood); 2007; 26(3):731-40. PubMed ID: 17485751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug product selection: the Florida experience revisited.
    Clouse EH; McCormick WC; Angorn RA; Kimberlin CL; Bradham DD
    Am J Public Health; 1985 Mar; 75(3):283-4. PubMed ID: 3976956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Science and law. The obvious war.
    Samardzija MR
    Science; 2007 Jan; 315(5809):190-1. PubMed ID: 17218511
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacists' and physicians' responses to the South Carolina Product Selection Act of 1978.
    Sumner ED; Karig AW; Hunt HH
    Contemp Pharm Pract; 1982; 5(2):124-9. PubMed ID: 10256911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacy practice acts: a five-year follow-up.
    Munger MA; Stilling WJ; Gardner SF
    Ann Pharmacother; 1993 May; 27(5):560-5. PubMed ID: 8347902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nifedipine labeling illustrates the pediatric dilemma for off-patent drugs.
    Adcock KG; Wilson JT
    Pediatrics; 2002 Feb; 109(2):319-21. PubMed ID: 11826214
    [No Abstract]   [Full Text] [Related]  

  • 33. Physicians, pharmacists, pharmaceutical manufacturers: partners in patient care, partners in litigation?
    Willig SH
    Spec Law Dig Health Care (Mon); 1987 Feb; 8(12):7-40. PubMed ID: 10280590
    [No Abstract]   [Full Text] [Related]  

  • 34. The patient medication instruction (PMI) leaflet: regulatory and evidentiary ramifications.
    Yacura M
    Spec Law Dig Health Care (Mon); 1986 Mar; 8(1):7-27. PubMed ID: 10276993
    [No Abstract]   [Full Text] [Related]  

  • 35. Perspectives. FDA scandal: white hats, black hats, gray areas.
    Wiener JO
    Faulkner Grays Med Health; 1989 Dec; 43(48):suppl 6 p.. PubMed ID: 10296081
    [No Abstract]   [Full Text] [Related]  

  • 36. The federal preemption debate in pharmaceutical labeling product liability actions.
    Gross JM; Curry JA
    Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866
    [No Abstract]   [Full Text] [Related]  

  • 37. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality?
    Marsh DA; Hoar ME
    Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generic drug equivalents: opening Pandora's Rx.
    Regulation; 1979; 3(3):4-5. PubMed ID: 10242344
    [No Abstract]   [Full Text] [Related]  

  • 39. Potential pathways for abbreviated approval of generic biologics under existing law and proposed reforms to the law.
    Dinh TQ
    Food Drug Law J; 2007; 62(1):77-137. PubMed ID: 17444027
    [No Abstract]   [Full Text] [Related]  

  • 40. Liability for errors in expanded pharmacy practice: issues for technicians and pharmacists.
    Cowley E; Baker KR
    J Am Pharm Assoc (Wash); 2000; 40(5 Suppl 1):S56-7. PubMed ID: 11029871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.